FRANKLIN LAKES, N.J., Sept. 17, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the placement of the 1,000th BD Rhapsody™ ...
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the commercial launch of a new single-cell research tool to help scientists better understand how the ...
BD (Becton, Dickinson and Company), a leading global medical technology company, announced a new instrument for single-cell multiomics analysis that will enable scientists to run high-throughput ...
Becton, Dickinson and Company BDX, popularly known as BD, announced a multi-year collaboration with Opentrons Labworks, Inc. on Wednesday. Per the agreement, BD and Opentrons are expected to integrate ...
IMU's AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyzed in real time.Waters Biosciences' technologies, ...
Virum, Denmark. 1 st February 2021 - Life Science Newswire - Immudex ApS has been collaborating with BD (Becton, Dickinson and Company) to create improved solutions for T-cell multi-omics research.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results